GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » Asset Turnover

American Cryostem (American Cryostem) Asset Turnover : 0.04 (As of Jun. 2022)


View and export this data going back to 2010. Start your Free Trial

What is American Cryostem Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. American Cryostem's Revenue for the three months ended in Jun. 2022 was $0.04 Mil. American Cryostem's Total Assets for the quarter that ended in Jun. 2022 was $1.10 Mil. Therefore, American Cryostem's Asset Turnover for the quarter that ended in Jun. 2022 was 0.04.

Asset Turnover is linked to ROE % through Du Pont Formula. American Cryostem's annualized ROE % for the quarter that ended in Jun. 2022 was 87.63%. It is also linked to ROA % through Du Pont Formula. American Cryostem's annualized ROA % for the quarter that ended in Jun. 2022 was -146.85%.


American Cryostem Asset Turnover Historical Data

The historical data trend for American Cryostem's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem Asset Turnover Chart

American Cryostem Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.33 0.97 0.25 0.40 0.02

American Cryostem Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 -0.26 0.06 0.03 0.04

Competitive Comparison of American Cryostem's Asset Turnover

For the Biotechnology subindustry, American Cryostem's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Cryostem's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Cryostem's Asset Turnover distribution charts can be found below:

* The bar in red indicates where American Cryostem's Asset Turnover falls into.



American Cryostem Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

American Cryostem's Asset Turnover for the fiscal year that ended in Sep. 2021 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Sep. 2021 )/( (Total Assets (A: Sep. 2020 )+Total Assets (A: Sep. 2021 ))/ count )
=0.021/( (1.477+1.056)/ 2 )
=0.021/1.2665
=0.02

American Cryostem's Asset Turnover for the quarter that ended in Jun. 2022 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2022 )/( (Total Assets (Q: Mar. 2022 )+Total Assets (Q: Jun. 2022 ))/ count )
=0.043/( (1.132+1.058)/ 2 )
=0.043/1.095
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


American Cryostem  (OTCPK:CRYO) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

American Cryostem's annulized ROE % for the quarter that ended in Jun. 2022 is

ROE %**(Q: Jun. 2022 )
=Net Income/Total Stockholders Equity
=-1.608/-1.835
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1.608 / 0.172)*(0.172 / 1.095)*(1.095/ -1.835)
=Net Margin %*Asset Turnover*Equity Multiplier
=-934.88 %*0.1571*-0.5967
=ROA %*Equity Multiplier
=-146.85 %*-0.5967
=87.63 %

Note: The Net Income data used here is four times the quarterly (Jun. 2022) net income data. The Revenue data used here is four times the quarterly (Jun. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

American Cryostem's annulized ROA % for the quarter that ended in Jun. 2022 is

ROA %(Q: Jun. 2022 )
=Net Income/Total Assets
=-1.608/1.095
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-1.608 / 0.172)*(0.172 / 1.095)
=Net Margin %*Asset Turnover
=-934.88 %*0.1571
=-146.85 %

Note: The Net Income data used here is four times the quarterly (Jun. 2022) net income data. The Revenue data used here is four times the quarterly (Jun. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


American Cryostem Asset Turnover Related Terms

Thank you for viewing the detailed overview of American Cryostem's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


American Cryostem (American Cryostem) Business Description

Traded in Other Exchanges
N/A
Address
1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724
American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.
Executives
John S Arnone director, officer: Chairman 111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski director, officer: COO 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc. 10 percent owner 188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill 10 percent owner 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina director, 10 percent owner, officer: President and Director 1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915